HubSpot

HubSpot, Inc. (HUBS) (Q1FY25) – Advancing health while redefining care

Highlights of the report

HubSpot has delivered a consistent record of top-line growth, supported by a steadily expanding customer base and a reliable subscription revenue model.

CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.

 

CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).

 

Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

HubSpot, Inc., together with its subsidiaries, provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

 In Q1FY25, the company reported revenue of over $714mn, representing a year-over-year growth rate of 16%. This growth was driven primarily by strong performance in subscription services, which
accounted for nearly 98% of total revenue.

 HubSpot stock price declined by ~9.03% in the past 1-year. The stock has a 52-week high of $819.71 and its 52-week low is $450.09. The stock price showed a downward trend in past 3 months period, declining by 14.45%.

 Executive Summary

• CrispIdea Forecast

– Income Statement

– Balance Sheet

– Cash Flow

– Common Size Ratio Analysis

– CrispIdea Segment Forecast

• Valuation & Historical Performance

– P/E Analysis

– CrispIdea Valuation

– Peer Comparison

– Ratio Analysis

– Economic Value-Added Analysis

– Du Pont Analysis

– CrispIdea Forecast Relative to Consensus

– Consensus Momentum

– Segment Performance

– Key Developments

– M&A Deals

• Ownership

• Stock Price Performance

• Crispidea Coverage

Report details

HubSpot, Inc. (HUBS) (Q1FY25) – Advancing health while redefining care

Price

$248.00

Company Reports

Sector Reports